Interim results to 30 September were characterised by a tripling of revenues to £6.7m, £1.2m of adjusted EBITDA, operating cashflow (£0.5m, despite £0.9m increase in inventory levels) and period-end cash of £1.7m. The outlook remains very positive, driven by: (i) sustainably higher-than-pre-pandemic order books; (ii) the prospect of first sales-based royalties from Actizone in FY 2022, which Solvay describes as being a potential blockbuster technology; and (iii) further monetisation events, whic ....
07 Dec 2020
Byotrol - Strong interim results and exciting times ahead
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Byotrol - Strong interim results and exciting times ahead
Byotrol plc (BYOT:LON) | 0.1 0 0.0% | Mkt Cap: 0.57m
- Published:
07 Dec 2020 -
Author:
Mark Brewer | Cavendish Research -
Pages:
12
Interim results to 30 September were characterised by a tripling of revenues to £6.7m, £1.2m of adjusted EBITDA, operating cashflow (£0.5m, despite £0.9m increase in inventory levels) and period-end cash of £1.7m. The outlook remains very positive, driven by: (i) sustainably higher-than-pre-pandemic order books; (ii) the prospect of first sales-based royalties from Actizone in FY 2022, which Solvay describes as being a potential blockbuster technology; and (iii) further monetisation events, whic ....